Using 23andMe to Reunite Families at the Border Comes With Serious Privacy Risks
By Tonya Riley,
Mother Jones [Cites CGS' Marcy Darnovsky]
| 06. 22. 2018
On Wednesday, President Donald Trump announced an end to administration’s policy of separating families at the border. But the administration hasn’t figured out how to reunite the parents and children that have already been split apart. A day after Trump’s announcement, Rep. Jackie Speier (D-Calif.) suggested a novel idea: recruit 23andMe, the DNA-testing company, to help separated families find missing relatives. The company itself quickly volunteered its services for the cause. But legal and genetic experts say that the solution might cause more harm than good.
Speier told Buzzfeed News on Thursday that she spoke with executives at 23andMe, which is headquartered in the congresswoman’s district, about providing testing assistance to reunite families at the border. By Thursday evening, 23andMe CEO Anne Wojcicki said that the company “would welcome any opportunity to help” and was “waiting to see the best way to follow up and make it happen.” (23andMe donated $5,000 to Speier’s 2016 campaign.)
“I implore the President, Attorney General Sessions, and HHS Secretary Azar to accept this generous and altruistic offer, particularly in light of the fact that...
Related Articles
By Emma McDonald Kennedy
| 10.29.2026
At the beginning of Nathan Fielder and Lance Oppenheim’s blockbuster documentary You Can See Everything, Billy Evans (partner of Theranos founder and convicted fraudster Elizabeth Holmes), says that they decided to do the film for one purpose: “radical transparency.” As they work on “Theranos 2.0,” Evans and Holmes want to show the public that she has been misunderstood –– painted as a liar and a fraud in the public imagination (and the courts) despite, as she claims in the...
By Jonquilyn Hill, Vox | 10.18.2026
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...